Upstream Biosciences Appoints Dr. Michael Hayden Killam Professor of Medical Genetics and the Canada Research Chair in Human Genetics to Its Scientific Advisory Board
Red Orbit (Free subscription) | 01/10/2008
Upstream Biosciences Inc. (OTCBB: UPBS) today announced the appointment of Dr. Michael Hayden, MD, PhD, FRCPC to its Scientific Advisory Board (SAB). Dr. Hayden has co-founded three companies: Xenon Pharmaceuticals, Aspreva Pharmaceuticals Inc., and Neurovir.
- add comment
- send to a friend
- Explore : Canada














